No Priors: Artificial Intelligence | Technology | Startups
If DNA is Code, Can AI Help Write It? Scaling Cell Programming and Synthetic Biology, with Ginkgo Bioworks Co-founder and CEO Jason Kelly
Sep 28, 2023
Jason Kelly, co-founder and CEO of Ginkgo Bioworks and an MIT Ph.D. in Biological Engineering, dives into the intersection of AI and synthetic biology. He discusses how DNA acts as a code akin to software, highlighting innovations in protein engineering. Kelly illustrates pandemic preparedness through advancements in synthetic biology and the importance of AI in drug discovery. The conversation sheds light on corporate governance in biotech startups and the evolutionary insights that can optimize biological systems for future research.
37:00
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Synthetic biology uses DNA as code to make cells as easy to work with as computers, integrating AI to enhance design and optimization processes.
- The integration of advanced technologies, like AI, can enhance global biosecurity by enabling early detection and rapid responses to infectious disease outbreaks.
Deep dives
Synthetic biology and its potential impact
Synthetic biology is described as the digital revolution in biology. The focus is on building developer tools and production infrastructure to make cells as easy to work with as computers. The core idea is that DNA is code, and inside cells, DNA functions like tape. However, the analogy ends there as the cell's behavior is vastly different from a digital system. Synthetic biology has been exploring what can be brought over from programming into the biological world, with AI being the latest technology being integrated.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
